DRREDDY Dr Reddy's Laboratories Ltd Legal Disputes Announcement 2024 - China Regulatory Action Dr. Reddys Laboratories has been suspended from selling Atomoxetine Hydrochloride Capsules in China due to non-compliance with manufacturing quality standards, impacting its eligibility for national drug procurement until February 2026; the company is currently assessing the financial implications..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd